Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil.
Lobato CMO, Codes L, Silva GF, Souza AFM, Coelho HSM, Pedroso MLA, Parise ER, Lima LMSTB, Borba LA, Evangelista AS, Rezende REF, Cheinquer H, Kuniyoshi ASO, Aires RS, Quintela EHD, Mendes LSC, Nascimento FCV, Medeiros Filho JEM, Ferraz MLCG, Abdala E, Bittencourt PL; Members of the Brazilian Real-Life Study about HCV treatment; Members of the Brazilian Real-Life Study about HCV treatment. Lobato CMO, et al. Among authors: parise er. Ann Hepatol. 2019 Nov-Dec;18(6):849-854. doi: 10.1016/j.aohep.2019.08.001. Epub 2019 Aug 30. Ann Hepatol. 2019. PMID: 31537509 Free article.
Peginterferon alfa-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy.
Parise E, Cheinquer H, Crespo D, Meirelles A, Martinelli A, Sette H, Gallizi J, Silva R, Lacet C, Correa E, Cotrim H, Fonseca J, Paraná R, Spinelli V, Amorim W, Tatsch F, Pessoa M; Brazilian Pegasys Cooperative Study Group. Parise E, et al. Braz J Infect Dis. 2006 Feb;10(1):11-6. doi: 10.1590/s1413-86702006000100003. Epub 2006 Jun 2. Braz J Infect Dis. 2006. PMID: 16767309 Free article.
Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile.
Cotrim HP, Parise ER, Oliveira CP, Leite N, Martinelli A, Galizzi J, Silva Rde C, Mattos A, Pereira L, Amorim W, Ivantes C, Souza F, Costa M, Maia L, Pessoa M, Oliveira F. Cotrim HP, et al. Among authors: parise er. Ann Hepatol. 2011 Jan-Mar;10(1):33-7. Ann Hepatol. 2011. PMID: 21301007 Free article.
Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial.
Pessôa MG, Cheinquer H, Almeida PR, Silva GF, Lima MP, Paraná R, Lacerda MA, Parise ER, Pernambuco JR, Pedrosa SS, Teixeira R, Sette H Jr, Tatsch F. Pessôa MG, et al. Among authors: parise er. Ann Hepatol. 2012 Jan-Feb;11(1):52-61. Ann Hepatol. 2012. PMID: 22166561 Free article. Clinical Trial.
Latin American Association for the Study of the Liver recommendations on treatment of hepatitis C.
Méndez-Sánchez N, Paraná R, Cheinquer H, Alves de Mattos A, Gadano A, Silva M, Pessôa MG, Gomes-Ferraz ML, Soza A, Mendes-Correa MC, Chávez-Tapia NC, Dagher L, Padilla M, Hernandez N, Sánchez-Avila JF, Contreras F, Moraes-Coelho HS, Parise ER, Bessone F, Uribe M; Latin American Association for the Study of the Liver. Méndez-Sánchez N, et al. Among authors: parise er. Ann Hepatol. 2014 Aug;13 Suppl 2:s4-66. Ann Hepatol. 2014. PMID: 25185535 Free article. Review. No abstract available.
81 results